168 related articles for article (PubMed ID: 2567779)
1. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2.
Hatano K; Ishiwata K; Kawashima K; Hatazawa J; Itoh M; Ido T
J Nucl Med; 1989 Apr; 30(4):515-22. PubMed ID: 2567779
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
[TBL] [Abstract][Full Text] [Related]
3. Measurement of D2 dopamine receptor-specific carbon-11-YM-09151-2 binding in the canine brain by PET: importance of partial volume correction.
Hatazawa J; Hatano K; Ishiwata K; Itoh M; Ido T; Kawashima K; Meguro K; Watanuki S; Seo S
J Nucl Med; 1991 Apr; 32(4):713-8. PubMed ID: 1672888
[TBL] [Abstract][Full Text] [Related]
4. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
5. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
Altar CA; Kim H; Marshall JF
J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
[TBL] [Abstract][Full Text] [Related]
6. Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics.
Assié MB; Sleight AJ; Koek W
Eur J Pharmacol; 1993 Jun; 237(2-3):183-9. PubMed ID: 7689973
[TBL] [Abstract][Full Text] [Related]
7. In vivo binding of [11C]nemonapride to sigma receptors in the cortex and cerebellum.
Ishiwata K; Senda M
Nucl Med Biol; 1999 Aug; 26(6):627-31. PubMed ID: 10587100
[TBL] [Abstract][Full Text] [Related]
8. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of omega-[18F]fluoroalkyl analogs of YM-09151-2 for the measurement of D2-dopamine receptors with PET.
Hatano K; Ido T; Ishiwata K; Hatazawa J; Itoh M; Kawashima K; Iwata R
Int J Rad Appl Instrum A; 1990; 41(6):551-5. PubMed ID: 2163373
[TBL] [Abstract][Full Text] [Related]
11. Autoradiography of dopamine D2 receptors using [3H]YM-09151-2.
Cox RF; Waszczak BL
Eur J Pharmacol; 1991 Jun; 199(1):103-6. PubMed ID: 1680055
[TBL] [Abstract][Full Text] [Related]
12. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
Langer O; Halldin C; Dollé F; Swahn CG; Olsson H; Karlsson P; Hall H; Sandell J; Lundkvist C; Vaufrey F; Loc'h C; Crouzel C; Mazière B; Farde L
Nucl Med Biol; 1999 Jul; 26(5):509-18. PubMed ID: 10473189
[TBL] [Abstract][Full Text] [Related]
13. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
Kobayashi T; Shimizu H; Toru M
Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
[TBL] [Abstract][Full Text] [Related]
14. Specific binding of [11C]spiroperidol in rat brain in vivo.
Arnett CD; Fowler JS; Wolf AP; MacGregor RR
J Neurochem; 1983 Feb; 40(2):455-9. PubMed ID: 6185638
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
Zhang MR; Haradahira T; Maeda J; Okauchi T; Kawabe K; Noguchi J; Kida T; Suzuki K; Suhara T
Nucl Med Biol; 2002 Feb; 29(2):233-41. PubMed ID: 11823129
[TBL] [Abstract][Full Text] [Related]
16. Effects of reserpine treatment on the dopamine receptor binding of [3H/11C]nemonapride in the mouse and rat brain.
Ishiwata K; Onoguchi K; Toyama H; Noguchi J; Senda M
Ann Nucl Med; 1997 Feb; 11(1):21-6. PubMed ID: 9095318
[TBL] [Abstract][Full Text] [Related]
17. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
Nakajima T; Iwata K
Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
[TBL] [Abstract][Full Text] [Related]
18. Quantitative ex vivo and in vitro receptor autoradiography using 11C-labeled ligands and an imaging plate: a study with a dopamine D2-like receptor ligand [11C]nemonapride.
Ishiwata K; Ogi N; Tanaka A; Senda M
Nucl Med Biol; 1999 Apr; 26(3):291-6. PubMed ID: 10363800
[TBL] [Abstract][Full Text] [Related]
19. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
[TBL] [Abstract][Full Text] [Related]
20. Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors.
Terai M; Usuda S; Kuroiwa I; Noshiro O; Maeno H
Jpn J Pharmacol; 1983 Aug; 33(4):749-55. PubMed ID: 6138453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
